Insmed to present five respiratory-drug abstracts at ERS Congress 2026

Verifying
  • Insmed announced five accepted research abstracts for the European Respiratory Society Congress 2026.
  • Five abstracts will showcase data on Insmed’s respiratory drugs.
  • ENCORE Phase 3b results on ARIKAYCE are among the presentation highlights.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.